BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26762354)

  • 1. Uncommon association of cerebral meningioma, parathyroid adenoma and papillary thyroid carcinoma in a patient harbouring a rare germline variant in the CDKN1B gene.
    Bugalho MJ; Domingues R
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26762354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia type 4.
    Lee M; Pellegata NS
    Front Horm Res; 2013; 41():63-78. PubMed ID: 23652671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia syndromes associated with mutation of p27.
    Lee M; Pellegata NS
    J Endocrinol Invest; 2013 Oct; 36(9):781-7. PubMed ID: 23800691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid adenoma and nonmedullary thyroid carcinoma association.
    Simpson RJ; Moss J
    Otolaryngol Head Neck Surg; 1989 Nov; 101(5):584-7. PubMed ID: 2574436
    [No Abstract]   [Full Text] [Related]  

  • 6. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
    Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma.
    Sato M; Miyauchi A; Namihira H; Bhuiyan MM; Imachi H; Murao K; Takahara J
    Endocrine; 2000 Jun; 12(3):223-6. PubMed ID: 10963041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.
    Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G
    Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
    Georgitsi M
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
    Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia, the old and the new: a mini review.
    Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
    G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual variant of multiple endocrine neoplasia syndrome: a case report.
    Banik S; Hasleton PS; Lyon RL
    Histopathology; 1984 Jan; 8(1):135-44. PubMed ID: 6142857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies.
    Chevalier B; Odou MF; Demonchy J; Cardot-Bauters C; Vantyghem MC
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):124-125. PubMed ID: 32386678
    [No Abstract]   [Full Text] [Related]  

  • 17. Undefined complications of parathyroid adenoma, parathyroid hyperplasia (primary hyperparathyroidism), thyroid follicular adenoma, thyroid papillary carcinoma, temporal astrocytoma, cerebellar meningioma, and hemangioma of external auditory meatus and oral papilloma.
    Yamakita N; Ikeda T; Shimizu Y; Hirata T; Murai T; Kawamura S; Komaki T; Kitada M
    Intern Med; 2000 Oct; 39(10):814-9. PubMed ID: 11030206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
    Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
    Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 2A (MEN-2A): natural history, screening, and central registration.
    Brouwers-Smalbraak GJ; Vasen HF; Struyvenberg A; Nieuwenhuijzen Kruseman AC; Helsloot MH; Lips CJ
    Neth J Med; 1986; 29(4):111-7. PubMed ID: 2872602
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
    Lavezzi E; Brunetti A; Smiroldo V; Nappo G; Pedicini V; Vitali E; Trivellin G; Mazziotti G; Lania A
    Front Endocrinol (Lausanne); 2022; 13():773143. PubMed ID: 35355569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.